Across TCGA pan-cancer cohorts, EIF4EP1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated EIF4EP1 data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher EIF4EP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated EIF4EP1 expression acts as an unfavorable survival marker, although some lineages such as ACC and HNSC show a favorable association.
THCA, CESC, and ACC are the cancer types where EIF4EP1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.